Dieser Anti-CEACAM5 (Tusamitamab Biosimilar) Antikörper ist ein Humanized Monoklonal Antikörper zur Detektion von CEACAM5 (Tusamitamab Biosimilar) in FACS und in vivo. Geeignet für Human.
Produktnummer ABIN7795147
Kurzübersicht für Rekombinanter CEACAM5 (Tusamitamab Biosimilar) Antikörper (ABIN7795147)
Target
CEACAM5 (Tusamitamab Biosimilar)
Antikörpertyp
Recombinant Antibody
Reaktivität
Human
Wirt
Humanized
Klonalität
Monoklonal
Konjugat
Dieser CEACAM5 (Tusamitamab Biosimilar) Antikörper ist unkonjugiert
Applikation
Flow Cytometry (FACS), In vivo Studies (in vivo)
Güteklasse
Research Grade
Expressionssystem
Mammalian cells
Verwendungszweck
Tusamitamab Biosimilar, Human CEACAM5 Monoclonal Antibody
Produktmerkmale
What is tusamitamab biosimilar research grade? Tusamitamab is a humanized IgG1-kappa monoclonal antibody targeting carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5) which is overexpressed in tumors including non-small cell lung cancer (NSCLC) and pancreatic ductal adenocarcinoma (PDAC), and is an attractive target for therapies based on CAR-T cell or/and ADCs. Tusamitamab ravtansine (SAR408701) is an antibody-drug conjugate (ADC) combining a humanized monoclonal antibody and a potent cytotoxic maytansinoid derivative (DM4) inhibiting microtubule assembly. Tusamitamab biosimilar uses the same protein sequences as the therapeutic antibody tusamitamab.